Canada Pension Plan Investment Board’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Buy
+700
New +$165K ﹤0.01% 1574
2026
Q1
– Sell
-1,600
Closed -$303K – 1874
2025
Q4
$303K Sell
1,600
-1,900
-54% -$365K ﹤0.01% 1516
2025
Q3
$620K Sell
3,500
-500
-13% -$74.3K ﹤0.01% 1030
2025
Q2
$455K Buy
+4,000
New +$428K ﹤0.01% 1031
2021
Q1
– Sell
-7,507
Closed -$466K – 1424
2020
Q4
$466K Buy
+7,507
New +$428K ﹤0.01% 1153
2020
Q3
– Sell
-26
Closed -$2K – 1238
2020
Q2
$2K Sell
26
-6,630
-100% -$420K ﹤0.01% 1363
2020
Q1
$302K Buy
6,656
+1,740
+35% +$98.6K ﹤0.01% 1063
2019
Q4
$320K Buy
+4,916
New +$329K ﹤0.01% 1213
2019
Q2
– Sell
-59,311
Closed -$4.65M – 1373
2019
Q1
$4.65M Sell
59,311
-82,074
-58% -$6.22M 0.01% 809
2018
Q4
$12M Buy
141,385
+82,715
+141% +$8.82M 0.03% 510
2018
Q3
$10M Buy
+58,670
New +$8.85M 0.02% 611
2016
Q4
– Sell
-36,548
Closed -$2.33M – 1127
2016
Q3
$2.33M Sell
36,548
-21,641
-37% -$1.59M 0.01% 673
2016
Q2
$4.33M Sell
58,189
-10,580
-15% -$785K 0.02% 561
2016
Q1
$4.59M Buy
68,769
+6,092
+10% +$370K 0.02% 563
2015
Q4
$4.24M Buy
62,677
+16,991
+37% +$1.05M 0.02% 566
2015
Q3
$2.44M Buy
+45,686
New +$2.77M 0.01% 708
2014
Q2
– Sell
-481
Closed -$20K – 1268
2014
Q1
$20K Buy
+481
New +$20K ﹤0.01% 1234

Other funds holding LGND

Canada Pension Plan Investment Board's LGND Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 700 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #1574 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in LGND as recently as Q4 2025.

Canada Pension Plan Investment Board first reported a position in LGND in Q1 2014 and has held it in 17 quarters since. The position peaked at $12M in Q4 2018. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Canada Pension Plan Investment Board held 700 shares of Ligand Pharmaceuticals worth $221K as of Q2 2026.
  • Ligand Pharmaceuticals was a new Canada Pension Plan Investment Board position in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1574 holding.
  • Canada Pension Plan Investment Board first reported a position in Ligand Pharmaceuticals in Q1 2014 and has held it in 17 quarters since.
  • Canada Pension Plan Investment Board's Ligand Pharmaceuticals position peaked at $12M in Q4 2018.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.